264 related articles for article (PubMed ID: 20070787)
1. Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials.
Ritsner MS
CNS Neurosci Ther; 2010; 16(1):32-44. PubMed ID: 20070787
[TBL] [Abstract][Full Text] [Related]
2. The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia.
Ritsner MS
Neuroscience; 2011 Sep; 191():91-100. PubMed ID: 21549182
[TBL] [Abstract][Full Text] [Related]
3. Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia.
Cai H; Zhou X; Dougherty GG; Reddy RD; Haas GL; Montrose DM; Keshavan M; Yao JK
Psychoneuroendocrinology; 2018 Apr; 90():43-51. PubMed ID: 29433072
[TBL] [Abstract][Full Text] [Related]
4. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging.
Vallée M; Mayo W; Le Moal M
Brain Res Brain Res Rev; 2001 Nov; 37(1-3):301-12. PubMed ID: 11744095
[TBL] [Abstract][Full Text] [Related]
5. Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial.
Ritsner MS; Gibel A; Shleifer T; Boguslavsky I; Zayed A; Maayan R; Weizman A; Lerner V
J Clin Psychiatry; 2010 Oct; 71(10):1351-62. PubMed ID: 20584515
[TBL] [Abstract][Full Text] [Related]
6. 'New' active steroids and an unforeseen mechanism of action.
Baulieu EE
C R Acad Sci III; 2000 Jun; 323(6):513-8. PubMed ID: 10923206
[TBL] [Abstract][Full Text] [Related]
7. Neurosteroids and potential therapeutics: Focus on pregnenolone.
Vallée M
J Steroid Biochem Mol Biol; 2016 Jun; 160():78-87. PubMed ID: 26433186
[TBL] [Abstract][Full Text] [Related]
8. [Neurosteroids: behavioral aspects and physiological implications].
Akwa Y; Baulieu EE
J Soc Biol; 1999; 193(3):293-8. PubMed ID: 10542960
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone (DHEA) augmentation in the management of schizophrenia symptomatology.
Strous RD
Essent Psychopharmacol; 2005; 6(3):141-7. PubMed ID: 15869021
[TBL] [Abstract][Full Text] [Related]
10. [New therapeutic avenues for neurosteroids in psychiatric diseases].
Froger N
Biol Aujourdhui; 2019; 213(3-4):131-140. PubMed ID: 31829933
[TBL] [Abstract][Full Text] [Related]
11. The role of dehydroepiandrosterone (DHEA) in schizophrenia.
Vuksan-Ćusa B; Šagud M; Radoš I
Psychiatr Danub; 2016 Mar; 28(1):30-3. PubMed ID: 26938818
[TBL] [Abstract][Full Text] [Related]
12. Strain differences of neurosteroid levels in mouse brain.
Tagawa N; Sugimoto Y; Yamada J; Kobayashi Y
Steroids; 2006 Sep; 71(9):776-84. PubMed ID: 16797626
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density.
Akwa Y; Sananès N; Gouézou M; Robel P; Baulieu EE; Le Goascogne C
J Cell Biol; 1993 Apr; 121(1):135-43. PubMed ID: 8458866
[TBL] [Abstract][Full Text] [Related]
14. DHEA, PREG and their sulphate derivatives on plasma and brain after CRH and ACTH administration.
Torres JM; Ortega E
Neurochem Res; 2003 Aug; 28(8):1187-91. PubMed ID: 12834258
[TBL] [Abstract][Full Text] [Related]
15. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.
Ritsner M; Maayan R; Gibel A; Weizman A
Eur Neuropsychopharmacol; 2007 Apr; 17(5):358-65. PubMed ID: 17123790
[TBL] [Abstract][Full Text] [Related]
16. Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders.
Pérez-Neri I; Montes S; Ojeda-López C; Ramírez-Bermúdez J; Ríos C
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1118-30. PubMed ID: 18280022
[TBL] [Abstract][Full Text] [Related]
17. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).
Maninger N; Wolkowitz OM; Reus VI; Epel ES; Mellon SH
Front Neuroendocrinol; 2009 Jan; 30(1):65-91. PubMed ID: 19063914
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of 4- and 5-ene steroid sulfates in human breast cyst fluids.
Maeda Y; Tanaka E; Fujiwara M; Watanabe R; Furusawa H; Matsu T; Nakahara H; Nanba K; Higashi S; Setoguchi T
J Steroid Biochem Mol Biol; 2002 Jul; 81(3):249-53. PubMed ID: 12163136
[TBL] [Abstract][Full Text] [Related]
19. Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence.
Marx CE; Bradford DW; Hamer RM; Naylor JC; Allen TB; Lieberman JA; Strauss JL; Kilts JD
Neuroscience; 2011 Sep; 191():78-90. PubMed ID: 21756978
[TBL] [Abstract][Full Text] [Related]
20. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
